MedTrace Logo

Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy

NCT00282685 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2021-10-26

No results posted yet for this study

Summary

Treatment of patients with diabetic neuropathy by intraarterial progenitor cell transplantation.

Conditions

  • Diabetic Neuropathies

Interventions

PROCEDURE

Intraarterial bone marrow progenitor cell transplantation

catheter delivery of stem cells

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Andreas M Zeiher, MD · Div. of Cardiology, University of Frankfurt, Germany

  • Dirk H Walter, MD · Div. of Cardiology, University of Frankfurt, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2008-12-31
Completion
2009-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00282685 on ClinicalTrials.gov